1 – 5 of 35
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Otitis media : Interactions between host and environment, immune and inflammatory responses
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
2023) In Allergy: European Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
-
Mark
Exploring the microbial landscape uncovering the pathogens associated with community-acquired pneumonia in hospitalized patients
(
- Contribution to journal › Article
-
Mark
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection
(
- Contribution to journal › Article
- 2022
-
Mark
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation
(
- Contribution to journal › Letter